Skip Navigation


UCLA Directory Map Calendar  
UCLA Stem Cell The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA
HOME
ABOUT
JOB OPENINGS
RESEARCH
RESOURCES
FAQ
PEOPLE
NEWS
EVENTS
SUPPORT THE CENTER
News

The Broad Foundation Donates $20 Million
to UCLA Stem Cell Institute

The Eli and Edythe Broad Foundation is donating $20 million to fund adult and embryonic stem cell research at UCLA, enhancing a program that brings together biologists, chemists, engineers, geneticists and other scientists  to develop new and more effective treatments for cancer, HIV/AIDS, Parkinson’s, metabolic disorders and other medical conditions.

In recognition of the gift, the Institute for Stem Cell Biology and Medicine at UCLA will be renamed the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. The gift will be used to purchase specialized, high-tech laboratory equipment and will support faculty recruitment through research grants and endowed professorships, enabling UCLA to continue its leadership in cutting-edge, multidisciplinary scientific and medical research. READ MORE....

For pictures and video of the ceremony...


2009

Drs. Don Kohn, Irvin Chen, and Dennis Slamon were awarded $49.2 million in CIRM grants for bench to bedside research in sickle cell disease, HIV/AIDS, and ovarian, colorectal, and brain cancers. READ MORE....


Drs. Bennet Novitch, Michael Teitell, Robb MacLellan, and Luisa Iruela-Arispe received California Institute of Regenerative Medicine (CIRM: Prop. 71) stem cell grants totaling $5.42 million for research that will uncover the basic mechanisms underlying stem cell biology and build a foundation that will support future research designed to translate stem cell science from the lab bench to the patient’s bedside. The grants constituted a third of the total CIRM basic biology awards. READ MORE....

hESC and iPSC are distinguished by gene expression. BSCRC faculty Drs. William Lowry and Kathrin Plath, and their associates found that human embryonic stem cells and skin cells reprogrammed into embryonic-like cells have inherent molecular differences, demonstrating for the first time that the two cell types are clearly distinguishable from one another. The data, pulished in Cell Stem Cell, suggest that embryonic stem cells and the reprogrammed cells, known as induced pluripotent stem (iPS) cells, have overlapping but still distinct gene expression signatures. Cell Stem Cell. Read more....

BSCRC member Dr. William Lowry and associates showed for the first time that human induced pluripotent stem cells (iPSC) can be differentiated into electrically active motor neurons. The discovery may aid in studying and treating neurological disorders.The research appeared in the early online edition of the journal Stem Cells. Read the story...

UCLA Broad Stem Cell Research Center received $3.93M from the California Institute of Regenerative Medicine (CIRM) to renew a grant to train young scientists to conduct stem cell research. The three-year competitive grant will fund the training of 16 graduate students, post-doctoral fellows and physicians conducting stem cell research per year. CIRM training grant funding to UCLA now totals $7.68M, the largest amount awarded to a stem cell center. Read the story...

BSCRC investigators led by Dr. Amander Clark, for the first time, reprogrammed human induced pluripotent stem cells (iPSC) into the cells that eventually become eggs and sperm, possibly opening the door for new treatments for infertility using patient-specific cell. The study appeared in the January 26, 2009, early online edition of the peer-reviewed journal Stem Cells. Read the story...

2008

Drs. Ann Zovein and Luisa Iruela-Arispe and colleagues provide definitive proof that endothelial cells give rise to blood stem cells during embryonic development.
The finding ultimately could lead to new therapies for certain blood disorders and cancers. Read the article...

UCLA stem cell scientists Hsian-Rong Tseng and Michael Phelps Receive $1.6 M in CIRM grants to develop innovative tools to aid in stem cell research.
Read more...

Dr. Zoran Galic, et.al., developed a generation of T lineage cells from human embryonic stem cells (hESC) in a feeder free system. The paper demonstrates that T cells can be differentiated from hESC in a system free of animal based support cells. The research suggests that hESC may have the potential to reconstitute the T cell arm of the immune system, or as a vehicle for gene therapeutic approaches to augment T cell immunity enabling their use in clinical work targeting cures for various diseases such as AIDS. Read the article...

Dr. Amander Clark and associates identified a transcriptional signature associated with malignant cancer stem cell emergence in testicular cancer.  The findings may lead to the development of a strategy to prevent malignant transformation in testicular cancer and preserve testicular tissue in order to ensure reproductive health in men diagnosed with this disease. Additionally, the research may lead to the development of strategies to minimize metastasis in men who present with the late stage or treatment resistance disease. Read the article...

Broad Stem Cell Research Center scientist Dr. Jerome Zack explains the new stem cell technology, induced pluripotent stem cells (iPSC), and the potential of the new technology. In an interview with CIRM, Dr. Zack explains that iPSC are made from human skin cells or possibly other cells and they have many of the characteristics of embryonic stem cells including the ability to create tissue specific cells. SEE THE VIDEO...

a. Read about Dr. Zack's CIRM grant to create iPSC...

b. Also read about BSCRC faculty Drs. William Lowry, Kathrin Plath, et. al., the first California scientists to create iPSC.

CIRM awards UCLA scientists, Drs. Brigitte Gomperts and Antoni Ribas, $5.45 million in grants to conduct leading-edge research that may shed light on the role of stem cells in the development of lung cancer and help to create a cancer-fighting immune system. Drs. Gomperts and Ribas were among 23 researchers from throughout the state chosen to receive New Faculty Awards, designed to encourage and foster the next generation of stem cell researchers.

Drs. Amander Clark and Jerome Zack each received grants from the California Institute for Regenerative Medicine (CIRM) to create new pluripotent human stem cell lines that may one day help scientists better understand, diagnose and treat serious injury and disease. READ MORE...

Director Owen Witte and colleagues received a $2.25 million grant to study prostate cancer stem cells and better define the role they play in cancer development, drug resistance and disease recurrence. UCLA was one of eight groups chosen from a nationwide pool of more than 100 proposals by the Prostate Cancer Foundation to receive a 2008 Challenge Award.

Hong Wu and BSCRC Investigators identified a type of leukemia stem cell and uncovered the molecular and genetic mechanisms that cause a normal blood stem cells to become cancerous. The discovery may lead to new therapies that target these leukemia stem cells, attacking the disease at its very root and killing the early cells that give rise to the mature cancer cells. The study appears in the May 22, 2008 issue of the journal Nature: read more online.....

BSCRC receives ~$20 million grant to create stem cell laboratories and innovative core resources to support basic to translational stem cell research.

UCLA BSCRC Investigators Create Heart and Blood Cells fro Reprogrammed Skin Cells
Robb MacLellan and colleagues grew functioning cardiac cells using mouse skin cells that had been reprogrammed into cells with the same unlimited properties as embryonic stem cells.            The finding, published in Stem Cells is the first to show that induced pluripotent stem cells or iPS cells, which don’t involve the use of embryos or eggs, can be differentiated into the three types of cardiovascular cells needed to repair the heart and blood vessels. Researchers also were able to differentiate the iPS cells into several types of blood cells, which may one day aid in treating blood diseases and in bone marrow transplantation. Stem Cell: online...

Broad Stem Cell Research Center Investigators Identify Genetic Differences in hESC that could Control Individual Traits and Disease Susceptability READ MORE: Stem Cell: online Mar 27, 2008.

UCLA scientist Hanna Mikkola, MD, PhD, reports blood stem cells originate and are nurtured in the placenta (March 5, 2008)
UCLA Broad Stem Cell Research Center scientists, led by Dr. Hanna Mikkola, discovered that blood stem cells, the cells that later differentiate into all the cells in the blood supply, originate and are nurtured in the placenta.The discovery solves a long-standing biological mystery and may allow researchers to mimic the specific embryonic microenvironment necessary for development of blood stem cells in cell culture and grow them for use in treating diseases like leukemia and aplastic anemia.

Broad Stem Cell Center Researchers Reprogram Human Skin Cells Into Cells with the same Properties as Human Embryonic Stem Cells (February 11, 2008)
UCLA Broad Stem Cell Center scientists Kathrin Plath and William Lowry, used genetic alteration to turn back the clock on human skin cells and create cells that are nearly identical to human embryonic stem cells, which have the ability to become every cell type found in the human body. Four regulator genes were used to create the cells, called induced pluripotent stem cells or iPS cells. The article is published in PNAS, v105, n8: February 26, 2008.

Broad Stem Cell Center Researcher Uncovers Unique Reglatory Mechanism of Gene Expression in Mouse Embryonic Stem Cells (February 7, 2007) The article is published in Cell Stem Cell, v2, n2: February 7, 2008.

2007

Three UCLA Scientists Receive Stem Cell Grants Totaling $7.5 million (December 12, 2007)
UCLA Broad Stem Cell Center scientists Siavash Kurdistani, MD, Hanna Mikkola, MD, PhD, and Kathrin Plath, PhD, received grants totaling $7.5 million from the California Institute for Regenerative Medicine (CIRM) to conduct leading-edge research that may help shed light on the developmental and molecular biology of stem cells.

UCLA Scientist Kathrin Plath wins prestigious NIH New Innovator Award from among 2,100 applicants nationwide (September 18, 2007)  More information...                 

ISCBM scientists produce a large quantity of highly pure functioning neurons from human embryonic stem cells (August 13, 2007). READ MORE: PNAS ARTICLE...

ISCBM Stem Cell Researchers Reprogram Normal Tissue Cells into Cells with the Same Properties as Embryonic Stem Cells (June 6, 2007)
Researchers at the UCLA Institute for Stem Cell Biology and Medicine were the first scientists in California to take normal tissue cells and reprogram them into cells with the same unlimited properties as embryonic stem cells, the cells that are able to give rise to every cell type found in the body. Kathrin Plath, PhD and colleagues turned mouse fibroblasts into pluripotent cells that, in every aspect tested, were identical to embryonic stem cells. READ MORE: CELL STEM CELL ARTICLE

Hear Dr. Plath discuss her research on KPPC 89.3 FM "Air Talk".
Go to Wednesday, June 6, 2007.

UCLA Stem Cell Institute Receives $2.86 Million Grant from the State to Create New Stem Cell Laboratory Space (June 5, 2007) READ MORE...

ISCBM Scientists Awarded More Than $5 Million in CIRM Comprehensive Grants
(March 16, 2007) READ MORE...

ISCBM Scientists Awarded More Than $4 Million in CIRM Seed Grants (February 19, 2007):
READ MORE...

2006

ISCBM ADDS FIVE INTERNATIONALLY RENOWNED SCIENTISTS TO ITS RESEARCH TEAM
(October 17, 2006)
Five internationally renowned young scientists have been recruited to the research team of the Institute for Stem Cell Biology and Medicine at UCLA (ISCBM). From such respected institutions as Harvard, MIT, Rockefeller University and Johns Hopkins University, the new UCLA faculty members are joining a well established, cross-disciplinary stem cell research team at the ISCBM that includes top senior scientists studying stem cells and their role in cancer, HIV/AIDS, metabolic diseases, immune systems, skeletal and cardiac disease, and neurological disorders.

All under 40, the four women and one man are among the top up-and-coming stem cell researchers in the world and represent the leading-edge of science, said Dr. Owen Witte, director of the stem cell institute. READ MORE... & MORE                                                                                                           

ISCBM Researcher Finds Neural Stem Cells Grown in the Laboratory are Inferior to those taken from Donated Fetal Tissue: July 26, 2006 Human Molecular Genetics.

Associated Press Showcases ISCBM July 24, 2006
ISCBM scientists and their work were showcased in a July 24, 2006 Associated Press (AP) story on President Bush's veto on expanding federal funding for stem cell research.  Faculty featured included Institute co-director Judith Gasson, Drs. Harley Kornblum, Hanna Mikkola, and Jerome Zack.  The AP report also appeared online in the Lexington Herald Leader: "Stem Cell Research Goes on Despite Federal Restrictions".

UCLA Researchers Transform Stem Cells Found in Human Fat Into Smooth Muscle Cells
July 24, 2006 ARTICLE: PDFfile.

ISCBM & AIDS INSTITUTE Researchers Discover Way to Develop T-cells From Human Embryonic Stem Cells, Raising Hopes for a Gene Therapy to Combat AIDS: July 3, 2006 ARTICLE: PDF File

UCLA NEWS 4/10/06:
CIRM Releases First Year Training Grant Funds, UCLA Receives Largest Award
Read More: PDF File

UCLA Medicine, Winter 2006
"UCLA's Stem Cell Research Pioneers" (PDF File)

UCLA Magazine, January 2006
"Where Stem Cells Stand" (PDF File)

UCLA News 1/24/06
"Free Symposium at UCLA Explores the Promise and Perils of Stem Cell Research and Regenerative Medicine"
Read More: PDF Article | Online Link

UCLA Cancer Discoveries, 2005-2006
"The Promise of Stem Cells" (PDF File)

2005

The Journal of Clinical Investigations, v115, n11 November 2005
"UCLA Director Gets the Goods as California Makes Good on its Stem Cell Initiative"
PDF File | Online Article

UCLA College Report, Summer 2005 Vol. 4
"First Steps in a Bold Scientific Adventure" (PDF File)

Jonsson Cancer Center Foundation News, Spring/Summer 2005
"JCCC Scientists Selected to Lead New UCLA Institute" Online Article

UCLA News 9/12/2005
"UCLA’s Institute for Stem Cell Biology and Medicine Receives $3.75 Million to Train Researchers"
Read More: Online Article | PDF Article

UCLA News 3/16/2005
"UCLA Launches $20 Million Stem Cell Institute to Investigate New Approaches to HIV, Cancer and Neurological Disorders"
Read More: Online Article | PDF Article

 

 


 

a
University of California Terms of Use/©2005 UC Regents Disability Resources Disability Resources